Clinical Trial

Radical Fimbriectomy for Young BRCA Mutation Carriers

Study acronym: FIMBRIECTOMIE
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
Some BRCA-mutated women are reluctant to undergo laparoscopic bilateral salpingo-oophorectomy. The goal of the bilateral laparoscopic radical fimbriectomy the investigators suggest, is to suppress the tubal source of possible dysplastic cells from which can stem this high grade tumor, while preserving a natural ovarian hormonal secretion.
Protocol Amendment History 13 amendments
This ClinicalTrials.gov record has been amended 13 times since 2012-05-29; most recent amendment 2026-03-16.
Status change: Recruiting → Active, Not Recruiting 2016-02-15
Trial Details
NCT Number NCT01608074
Lead Sponsor Centre Oscar Lambret
Collaborators: CTD-CNO, Laboratoire PRISM
Conditions BRCA1 Mutation, BRCA2 Mutation, Hereditary Breast and Ovarian Cancer
Enrollment 123 participants
Start Date 2012-01-09
Primary Completion 2033-08 (estimated)
Study Completion 2033-08 (estimated)
Updated on ClinicalTrials.gov 2026-03-18